Skip to main content

Part of the book series: Current Topics in Rehabilitation ((CURRENT REHAB))

Abstract

It is commonly acknowledged that neutrophil elastase (NE) is responsible for lung elastin degradation that leads to emphysema.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bieth J.G.: Elastases: catalytic and biological properties. In: Mecham R.P.(Ed) Regulation ofmatrix accumulation. New York, Academic Press, 1986; 217–320

    Google Scholar 

  2. Gast A., Dietemann-Molard A., Pelletier A., Pauli G., Bieth J.G.: The antielastase screen of the lower respiratory tract of al-proteinase inhibitor-sufficient patients with emphysema or pneumothorax. Am. Rev. Respir. Dis. 1990; 141: 880–883

    Article  PubMed  CAS  Google Scholar 

  3. Kao R.C., Whener N.G., Skubitz K.M., Gray B.H., Hoidal J.R.: Proteinase 3. A distinct human polymorphonuclear leukocyte proteinase that produces emphysema in hamsters. J. Clin. Invest. 1988; 82: 1963–1973

    Article  PubMed  CAS  Google Scholar 

  4. Goldschmeding R., van der Schoot C.E., ten Bokkel Huinink D., Hack C.E., van den Ende M.E., Kallenberg C.G.M., von dem Borne A.E.G.Kr.: Wegener’s granulomatosis autoantibodies identify a novel diisopropylfluorophosphate-binding protein in the lysosomes of normal human neutrophils. J. Clin. Invest. 1989; 84: 1557–1587

    Article  Google Scholar 

  5. Senior R.M., Connoly N.L., Cury J.D., Welgus H.G., Campbell E.J.: Elastin degradation by human alveolar macrophages. Am. Rev. Respir. Dis. 1989; 139: 1251–1256

    Article  PubMed  CAS  Google Scholar 

  6. Reilly J.J. Jr, Mason R.W., Chen P., Joseph L.J., Sukhatme V.P., Yee R., Chapmann H.A. Jr.: Synthesis and processing of cathepsin L, and elastase, by human alveolar macrophages. Biochem. J. 1989; 257: 493–498

    PubMed  CAS  Google Scholar 

  7. Bieth J.G.: Human neutrophil elastase. In: Robert L., Hornebeck W. (Eds.) Elastin and elastases. Boca Raton, CRC Press, 1989; vol II, 24–31

    Google Scholar 

  8. Weitz J.I., Crowley K.A., Landman S.L., Lipman B I, Yu J.: Increased neutrophil elastase activity in cigarette smokers. Ann. Intern. Med. 1987; 107: 680–682

    Article  PubMed  CAS  Google Scholar 

  9. Abbound R., Fera T., Ritcher A., Tabona M.Z., Johal S.Z.: Acute effect of smoking on the functional activity of alpha-l-proteinase inhibitor in bronchoalveolar lavage fluid. Am. Rev. Respir. Dis. 1985; 131: 79–85

    Google Scholar 

  10. Jochum M., Pelletier A., Boudier C., Pauli G., Bieth J.G.: The concentration of leukocyte elastase a,-proteinase inhibitor complex in bronchoalveolar lavage fluids from healthy human individual s. Am. Rev. Respir. Dis. 1985; 132: 913–914

    PubMed  CAS  Google Scholar 

  11. Damiano V.V., Tsang A., Kucich U., Abrams W.R., Rosenbloom J. Kimbel P., Fallahnejad M., Weinbaum G.: Immunolocalization of elastase in human emphysematous lungs. J. Clin. Invest., 1986; 78: 482–493

    Article  PubMed  CAS  Google Scholar 

  12. Takahashi H., Nukiwa T., Yoshimura K., Quick C.D., States D.J., Holmes M.D., Whang-Peng J., Knutsen T., Crystal R.G:: Structure of the human neutrophil elastase gene. J. Biol. Chem. 1988; 263: 14739–14747

    PubMed  CAS  Google Scholar 

  13. Bode W., An-Zhi W., Huber R., Meyer E., Travis J., Neumann S.: X-ray crystal structure of the complex of human leucocyte elastase (PMN elastase) and the third domain of the turkey ovomucoid inhibitor. EMBO J. 1986; 5: 2453–2458

    PubMed  CAS  Google Scholar 

  14. Ogushi F., Hubbard R.C., Fells G.A., Casolaro M.A., Curiel D.T., Brantly M.L., Crystal R.G.: Evaluation of the S-type of alpha-l-antitrypsin as an in vivo and in vitro inhibitor of neutrophil elastase. Am. Rev. Respir. Dis. 1988; 137: 364–370

    Article  PubMed  CAS  Google Scholar 

  15. Cox D.W., Levison H.: Emphysema of early onset associated with a complete deficiency of alphal-antitrypsin (null homozygotes). Am. Rev. Respir. Dis. 1988; 137: 371–375

    Article  PubMed  CAS  Google Scholar 

  16. Bieth J.G.: Pathophysiological interpretation of kinetic constants of protease inhibitors. Bull. Europ. Physiopath. Respir. 1980; 16 (suppl.): 183–195

    CAS  Google Scholar 

  17. Boudier C., Bieth J.G.: Mucus proteinase inhibitor: a fast-acting inhibitor of leucocyte elastase. Biochim. Biophys. Acta. 1989; 995: 36–41

    Article  PubMed  CAS  Google Scholar 

  18. Gast A., Bieth J.G.: Inhibition of human neutrophil elastase by acid soluble inter-a-trypsin inhibitor. Adv. Exp. Med. Biol. 1988; 240: 75–82

    Article  PubMed  CAS  Google Scholar 

  19. Salvesen G., Farley D., Shuman J., Przybyla A., Reilly C., Travis J.: Molecular cloning of human cathepsin G: structural similarity to mast cell and cytotoxic T lymphocyte proteinase. Biochemistry 1987; 26: 2289–2293

    Article  PubMed  CAS  Google Scholar 

  20. Holn P.A., Popescu N.C., Hanson R.D., Salvesen G., Ley T.J.: Genomic organization and chromosomal localization of the human cathepsin G gene. J. Biol. Chem. 1989; 264: 13412–13419

    Google Scholar 

  21. Boudier C., Holle C., Bieth J.G.: Stimulation of the elastolytic activity of leukocyte elastase by leukocyte cathepsin G. J. Biol. Chem. 1981; 256: 10256–10258

    PubMed  CAS  Google Scholar 

  22. Lucey E.C., Stone P.J., Breurer R., Christensen T.G., Calore J.D., Catanese A., Franzblau C., Snider G.L.: Effects of combined human neutrophil cathepsin G and elastase on induction of secretory cell metaplasia and emphysema in hamsters with in vitro observations on elastolysis by these enzymes. Am. Rev. Respir. Dis. 1985; 132: 362–366

    PubMed  CAS  Google Scholar 

  23. Cawston T.E.: Protein inhibitors of metallo-proteinases. In: Barrett A.J., Salvesen G. (Eds.) Proteinases inhibitors. New York, Elsevier, 1986; 589–610

    Google Scholar 

  24. Barrett A.J., Rawlings D., Davies M.E., Machleidt W., Salvesen G., Turk V.: Cysteine proteinase inhibitors of the cystatin superfamily. In: Barrett A.J., Salvesen G. (Eds.) Proteinases inhibitors. New York, Elsevier, 1986; 515–569

    Google Scholar 

  25. Hamdaoui A., Wund-Bisseret F., Bieth J.G.: Fast-solubilization of human lung elastin by Pseudomonas aeruginosa elastase. Am. Rev. Respir. Dis. 1987; 135: 860–863

    PubMed  CAS  Google Scholar 

  26. Hasty K.A., Pourmotabbed T.F., Goldberg G.I., Thompson J.P., Spinella D.G., Stevens R.M., Mainardi C.L.: Human neutrophil collagenase. A distinct gene product with homology to other matrix metalloproteinases. J. Biol. Chem. 1990; 265: 11421–11424

    PubMed  CAS  Google Scholar 

  27. Okada Y., Nakanishi I.: Activation of matrix metalloproteinase 3 (stromelysin) and matrix metalloproteinase 2 (“gelatinase”) by human elastase and cathepsin G. FEBS Lett. 1989; 249: 353–356

    Article  PubMed  CAS  Google Scholar 

  28. Weiss S.J.: Mechanisms of disease. Tissue destruction by neutrophils. N. Engl. J. Med. 1989; 320: 365–376

    Article  PubMed  CAS  Google Scholar 

  29. Sibille Y., Reynolds H.Y.: Macrophages and polymorphonuclear neutrophils in lung defence and injury. Am. Rev: Respir. Dis. 1990; 141: 471–501

    Article  CAS  Google Scholar 

  30. Chapman H.A. Jr., Reilly J.J. Jr., Kobzik L.: Role of plasminogen activator in degradation of extracellular matrix protein by live human alveolar macrophages. Am. Rev. Respir. Dis. 1988; 137: 412–419

    Article  PubMed  CAS  Google Scholar 

  31. Desrochers P.E., Weiss S.: Proteolytic inactivation of alpha-l-proteinase inhibitor by a neutrophil metalloproteinase. J. Clin. Invest. 1988; 81: 1646–1650

    Article  PubMed  CAS  Google Scholar 

  32. Vissers M.C.M., George P. M., Bathurt I.C., Brennan O.S., Winterbourn C.C.: Cleavage and inactivation of a1-antitrypsin by metalloproteinases released from neutrophils. J. Clin. Invest. 1988; 82: 706–711

    Article  PubMed  CAS  Google Scholar 

  33. Johnson D.A., Barrett A.J., Mason R.W.: Cathepsin L inactivates a1-proteinase inhibitor by cleavage in the reactive site region. J. Biol. Chem. 1986; 261: 14748–14751

    PubMed  CAS  Google Scholar 

  34. Virca G.D., Lyerly D., Kreger A., Travis J.: Inactivation of al-proteinase inhibitor by Serratia marcescens metalloproteinase. Biochim. Biophys. Acta 1982; 704: 267–271

    Article  PubMed  CAS  Google Scholar 

  35. Morihara K., Tsuzuki H., Harada M., Iwata T.: Purification of human plasma a1-proteinase inhibitor and its inactivation by Pseudomonas elastase. J. Biochem. 1984; 95: 795–804

    PubMed  CAS  Google Scholar 

  36. Potempa J. Watorek W., Travis J.: Inactivation of human at-proteinase inhibitor by Staphylococcus aureus proteinases. J. Biol. Chem. 1986; 261: 14330–14334

    PubMed  CAS  Google Scholar 

  37. Conlan J.W., Williams A., Ashworth L.A.E.: Inactivation of human a,-antitrypsin by a tissue-destructive protease of Legionella pneumophila. J. Gen. Microbiol. 1988; 134: 481–487

    PubMed  CAS  Google Scholar 

  38. Morii M., Travis J.: Amino acid sequence at the reactive site of human a1-antichymotrypsin. J. Biol. Chem. 1983; 258: 12749–12752

    PubMed  CAS  Google Scholar 

  39. Brower M.S., Harpel P.C.: Proteolytic cleavage and inactivation of aZ plasmin inhibitor and Cl inactivator by human polymorphonuclear leukocyte elastase. J. Biol. Chem. 1982;257:9854-

    Google Scholar 

  40. Okada Y., Watanabe S., Nakanishi I, Kishi J.I., Hayakawa T., Watorek W., Travis J., Nagase I.: Inactivation of tissue inhibitor of metalloproteinases by neutrophil elastase and other proteinases. FEBS Lett. 1988; 229: 157–160

    Article  PubMed  CAS  Google Scholar 

  41. Janoff A.: Emphysema: proteinase-antiproteinase imbalance. In Gallin J.I., Goldstein I.M, Snyderman R. (eds): Inflammation: basic principles and clinical correlates. New York, Raven Press, 1988; 803–814

    Google Scholar 

  42. Boudier C., Pelletier A., Pauli G., Bieth J.G.: The functional activity of a,-proteinase inhibitor in bronchoalveolar lavage fluids from healthy human smokers and non-smokers. Clin. Chim. Acta. 1983; 132: 309–315

    Article  PubMed  CAS  Google Scholar 

  43. Stone P.J., Calore J.D.: Functional a,-proteinase inhibitor in the lower respiratory tract of cigarette smokers is not decreased. Science 1983; 221: 1187–1189

    Article  PubMed  CAS  Google Scholar 

  44. Campbell E.J., Endicott S.K., Rios-Mollineda R.A.: Assessment of oxidation of a1-proteinase inhibitor in broncho-alveolar lining fluid by monoclonal immunoassay: comparison of smokers and non-smokers. Am. Rev. Respir. Dis. 1987; 135: A156

    Google Scholar 

  45. Lawrence D.A., Loskutoff D.J.: Inactivation of plasminogen activator inhibitor by oxidants. Biochemistry 1986; 25: 6351–6355

    Article  PubMed  CAS  Google Scholar 

  46. Banda M.J., Rice A.G., Griffin G.L., Senior R.M.: al-proteinase inhibitor is a neutrophil chemoattractant after proteolytic inactivation by macrophage elastase. J. Biol. Chem. 1988; 263: 4481–4484

    PubMed  CAS  Google Scholar 

  47. Banda M.J., Rice A.G., Griffin G.L., Senior R.M.: The inhibitory complex of human a,-proteinase inhibitor and human leukocyte elastase is a neutrophil chemoattractant. J. Exp. Med. 1988; 167: 1608 1615

    Google Scholar 

  48. Lonky S.A., Wohl H.: Stimulation of human leukocyte elastase by platelet factor 4. Physiologic, morphologic and biochemical effects on hamster lungs in vitro. J. Clin. Invest. 1981; 67: 817–826

    Article  PubMed  CAS  Google Scholar 

  49. Frommherz K., Bieth J.G.: Heparin decreases the rate constant for the inhibition of leucocyte elastase by ai-proteinase inhibitor. Eur. Resp. J. 1989;2 suppl. 5: 347S

    Google Scholar 

  50. Hubbard R.G., Sellers S., Czerski D., Stephens L., Crystal R.G.: Biochemical efficacity and safety of monthly augmentation therapy for a1antitrypsin deficiency. JAMA 1988; 260: 1259–1264

    Article  PubMed  CAS  Google Scholar 

  51. Fletcher D.S., Osinga D.G., Hand K.M., Dellea P.S., Ashe B.M., Mumford R.A., Davies P., Hagmann W., Finke P.E., Doherty J.B., Bonney R.J.: A comparison of a1-proteinase inhibitor methoxysuccinyl-Ala-Ala-Pro-Val-Chloromethylketone and specific ß-lactam inhibitors in an acute model of human polymorphonuclear leukocyte elastase-induced lung hemorrhage in the hamster. Am. Rev. Respir. Dis. 1990; 141: 672–677

    Article  PubMed  CAS  Google Scholar 

  52. Niewoehner D.E., Kleinerman J., Rice D.B.: Pathologic changes in the peripheral airways of young cigarette smokers. N. Engl. J. Med. 1974; 291: 755–758

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1992 Springer-Verlag London

About this chapter

Cite this chapter

Bieth, J.G. (1992). Lung Proteinases and Emphysema. In: Grassi, C., Travis, J., Casali, L., Luisetti, M. (eds) Biochemistry of Pulmonary Emphysema. Current Topics in Rehabilitation. Springer, London. https://doi.org/10.1007/978-1-4471-3771-9_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-3771-9_4

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-3773-3

  • Online ISBN: 978-1-4471-3771-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics